Compositions and methods for the treatment of sepsis
US6987166B2 · kind B2 · utility
11Cited by
13References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 11, 2001 |
| Grant date | Jan 17, 2006 |
| Priority date | — |
| Expiry date | Jun 11, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions and methods for the prevention and treatment of blood-borne and toxin mediated diseases, and in particular anti-C5a antibodies for the prevention and treatment of sepsis in humans as well as other animals. The present invention also relates to methods of generating anti-C5a antibodies employing C-terminal truncated C5a peptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.